Outsourcing

Pharmaceutical Outsourcing Present and Future

Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Navigating the Preclinical CRO Outsourcing Process

The need for preclinical testing expertise is growing as molecular complexity increases.

A Closer Look at Affinity Ligands

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

Pii Hires Roberto Almodóvar Febles as Head of Aseptic Operations

September 02, 2021

Febles will oversee day-to-day aseptic manufacturing at Pharmaceutics International, Inc.

Quotient Sciences Makes Multi-Million Dollar Investment to Expand Drug Substance Manufacturing Facility

September 01, 2021

Quotient Sciences is investing £6.3 million ($8.68 million) into their drug substance manufacturing capabilities.

AGC Biologics Breaks Ground on New Multipurpose Facility in Denmark

August 25, 2021

AGC Biologics has broken ground on a new multipurpose facility in Copenhagen, Denmark, that will increase capacity.

Lonza Invests in Drug Product Manufacturing Services in China

August 25, 2021

Lonza plans to establish drug product manufacturing capabilities at is site in Guangzhou, China, to produce clinical trial and commercial supply in the country.

Curia to Invest $35 Million in Expansions Into Rensselaer, NY Facility

August 19, 2021

Curia plans to expand the site’s commercial capabilities with this move.

Biotage Expands Lipid Capacity with New Facility

August 17, 2021

Biotage’s new facility in Cardiff, UK, will produce lipids using large-scale flash purification.

Putting the Patient at the Heart of Dosage Form Design

August 03, 2021

Dosage form priorities are shifting to focus on user-friendliness, leading to greater engagement with outsourcing partners earlier in development timelines.

Developing the Best Formulation Partnership

August 02, 2021

Collaborative partnerships can foster success in formulation development projects.

CMOs and CDMOs Adjust to Pandemic Response and Beyond

August 02, 2021

Investments, biologics, and the impact of COVID-19 will continue to shape the bio/pharmaceutical outsourcing industry for the near term.

Data Integrity Considerations for Vendor-Generated Data Associated with Analytical Testing

August 02, 2021

Sponsors should consider best practices for maintaining data generated during sample analysis and instrument maintenance.